Present address: The Department of Endocrinology, Zhongshan hospital, Fudan University, NO. 180 Fenglin Road, Shanghai, 200032, China.
Department of Endocrinology and Metabolism, Jinjiang Municipal Hospital, Jinjiang, 362200, China.
BMC Endocr Disord. 2021 Feb 18;21(1):27. doi: 10.1186/s12902-021-00694-w.
Although thyroid function has been demonstrated to be associated with non-alcoholic fatty liver disease (NAFLD) in different population, the prevalence and features of NAFLD in hyperthyroidism have not been reported. The present study aims to investigate the prevalence of NAFLD and association of thyroid function and NAFLD in hyperthyroidism patients.
This cross-sectional study was performed in Zhongshan Hospital, Fudan University, China. A total 117 patients with hyperthyroidism were consecutively recruited from 2014 to 2015. Thyroid function and other clinical features were measured, liver fat content was measured by color Doppler ultrasonically, NAFLD was defined in patients with liver fat content more than 9.15%. Statistical analyses were performed with SPSS software package version 13.0.
The prevalence of NAFLD was 11.97% in hyperthyroidism. Patient with NAFLD had lower free triiodothyronine (FT3) and free thyroxine (FT4) levels than patients without NAFLD (P < 0.05). After adjusting for age, gender, metabolic parameters and inflammation factors, higher FT3 were associated with lower liver fat content (β = - 0.072, P = 0.009) and decreased odds ratio of NAFLD (OR = 0.267, 95%CI 0.087-0.817, P = 0.021).
FT3 level was negatively associated with the liver fat content in this population. These results may provide new evidence in the role of thyroid hormone on the regulation of liver fat content and NAFLD.
尽管甲状腺功能与非酒精性脂肪性肝病(NAFLD)在不同人群中有关联,但甲状腺功能亢进症患者中 NAFLD 的患病率和特征尚未报道。本研究旨在调查甲状腺功能亢进症患者中 NAFLD 的患病率以及甲状腺功能与 NAFLD 的相关性。
本横断面研究在中国复旦大学中山医院进行。2014 年至 2015 年期间,连续招募了 117 例甲状腺功能亢进症患者。测量甲状腺功能和其他临床特征,使用彩色多普勒超声测量肝脂肪含量,肝脂肪含量大于 9.15%的患者定义为 NAFLD。使用 SPSS 软件包版本 13.0 进行统计分析。
甲状腺功能亢进症患者中 NAFLD 的患病率为 11.97%。患有 NAFLD 的患者游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)水平低于无 NAFLD 的患者(P<0.05)。在调整年龄、性别、代谢参数和炎症因素后,较高的 FT3 与较低的肝脂肪含量(β=−0.072,P=0.009)和降低的 NAFLD 比值比(OR=0.267,95%CI 0.087-0.817,P=0.021)相关。
FT3 水平与该人群的肝脂肪含量呈负相关。这些结果可能为甲状腺激素在调节肝脂肪含量和 NAFLD 中的作用提供新的证据。